- Citations, last 5 years
- 392
- Works, last 5 years
- 32
- h-index
- 57
- Scientists listed
- 26
- Grants since 2016
- 95
Grants received
2025–2027 · research · R44
Asymmetric nucleosome substrates to advance the study of the histone code
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2025–2027 · research · R44
Development of novel epigenetic biomarkers and detection reagents for aging
Sabrina Robin Hunt · EpiCypher (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Versatile genomics platform for unbiased analysis of chromatin-associated RNAs and nascent transcripts
Sabrina Robin Hunt · EpiCypher (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Biochemical and genomic tools to study histone ADP ribosylation signaling
Sabrina Robin Hunt · EpiCypher (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Versatile platform for genome-wide R-loop mapping for aging and neurodegenerative disease research
Bryan J Venters · EpiCypher (United States) · funded by National Institutes of Health
2024–2027 · research · R44
Versatile platform for genome-wide R-loop mapping for aging and neurodegenerative disease research
Bryan J Venters · EpiCypher (United States) · funded by National Institutes of Health
2024–2027 · research · R44
Versatile genomics platform for unbiased analysis of chromatin-associated RNAs and nascent transcripts
Sabrina Robin Hunt · EpiCypher (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Biochemical and genomic tools to study histone ADP ribosylation signaling
Sabrina Robin Hunt · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Development of ultra-efficient antibodies for single cell mapping applications
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2023–2024 · research · R43
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Development of ultra-efficient antibodies for single cell mapping applications
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2023–2024 · research · R43
Epigenomic analysis of cell-free nucleosomes for cancer research
Bryan J Venters · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Novel recombinant sensors to study histone ubiquitin signaling
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Novel recombinant sensors to study histone ubiquitin signaling
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Development of ultra-efficient antibodies for single cell mapping applications
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2023–2027 · research · R44
Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2023–2027 · research · R44
Epigenomic analysis of cell-free nucleosomes for cancer research
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Multiomic genomic mapping with long read sequencing
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2022–2024 · research · R44
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2026 · research · R44
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2026 · research · R44
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Multiomic genomic mapping with long read sequencing
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2022–2023 · research · R44
Multiomic genomic mapping with long read sequencing
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's disease
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
A molecular toolbox to accelerate drug development for histone lysine methylation regulators
Jonathan Michael Burg · EpiCypher (United States) · funded by National Institutes of Health
2022–2024 · research · R43
High-resolution genomic mapping of ssDNA and associated proteins for Alzheimer's disease research
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Development of a high-throughput epigenomic mapping platform to molecularly phenotype Crohn's disease
Andrea Lynn Johnstone · EpiCypher (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Engineered super-affinity reagents for detection of histone post-translational modifications
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2024 · research · R43
A novel platform for quantification of acute neuronal transcriptional responses
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health
2022–2023 · research · R44
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping
Michael-Christopher Keogh · EpiCypher (United States) · funded by National Institutes of Health
2022–2023 · research · R44
Engineered super-affinity reagents for detection of histone post-translational modifications
Zu-Wen Sun · EpiCypher (United States) · funded by National Institutes of Health